B1680
Bradyzide di(trifluoroacetate) salt hydrate
≥98%
别名:
(S)-1-[4-(4-Benzhydrylthiosemicarbazido)-3-nitrobenzenesulfonyl]-pyrrolidine-2-carboxylic acid [2-[(2-dimethylaminoethyl)methylamino]ethyl] amide
登录并加购，请在购物车里查看协议价、货期和发货地。
选择规格
变更视图
关于此项目
经验公式（希尔记法）:
C32H42N8O5S2 · 2C2HF3O2 · xH2O
分子量:
910.90 (anhydrous basis)
UNSPSC Code:
41106200
NACRES:
NA.32
MDL number:
Assay:
≥98%
Form:
solid
Biochem/physiol Actions
Potent, orally active, non-peptide B2 bradykinin receptor antagonist.
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
存储类别
11 - Combustible Solids
WGK
WGK 3
闪点 (F)
Not applicable
闪点 (°C)
Not applicable
PPE（个人防护设备）
Eyeshields, Gloves, type N95 (US)